ReviewAdvances in nutrition (Bethesda, Md.)2026
Plant-Derived Flavonoids Ameliorate Diabetic Nephropathy: Molecular Mechanisms and Therapeutic Potential.
Review in Advances in nutrition (Bethesda, Md.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic nephropathy (DN) is a major microvascular complication of diabetes mellitus and a leading cause of chronic kidney disease and end-stage renal disease. Although current therapeutic strategies can delay disease progression, they remain insufficient to reverse established renal injury. Plant-derived flavonoids, a class of natural polyphenolic compounds, have attracted increasing attention because of their diverse pharmacologic properties. This structured narrative review summarizes the major molecular mechanisms underlying the protective effects of plant-derived flavonoids against DN. A comprehensive literature search was conducted in PubMed, Web of Science, and MEDLINE from database inception through 25 December 2025. A total of 251 relevant studies were included (54 in vitro only, 107 in vivo only, and 90 involving both). The evidence indicates that plant-derived flavonoids may exert renoprotective effects through diverse mechanisms, including the modulation of inflammation, oxidative stress, fibrosis, autophagy, apoptosis, ferroptosis, and microRNA-mediated regulatory pathways. Collectively, these flavonoids, such as kaempferol, quercetin, puerarin, and (-)-epigallocatechin-3-gallate, demonstrate multitarget therapeutic potential against DN and may serve as promising adjunctive agents for disease management. However, the current evidence is predominantly derived from preclinical studies, and well-designed randomized controlled trials are required to further validate their efficacy and safety and to facilitate clinical translation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.